Literature DB >> 15797666

A unifying pathway for essential hypertension.

Richard J Johnson1, Bernardo Rodriguez-Iturbe, Duk-Hee Kang, Daniel I Feig, Jaime Herrera-Acosta.   

Abstract

We present the hypothesis that most cases of essential hypertension occur via two phases. The first phase is initiated by episodes of renal vasoconstriction induced by a hyperactive sympathetic nervous system, activation of the renin-angiotensin system, or hyperuricemia resulting from diet or genetics. During this phase the hypertension is salt resistant and renin dependent, and the kidney normal. Over time, preglomerular vascular disease develops (arteriolosclerosis), associated with tubulointerstitial inflammation; this shifts the hypertension to a salt-sensitive, volume-dependent, and renal-dependent pathway. This pathway unites many of the previous hypotheses on the etiology of hypertension, and offers insights into ways to prevent, ameliorate, or cure the underlying process.

Entities:  

Mesh:

Year:  2005        PMID: 15797666     DOI: 10.1016/j.amjhyper.2004.08.035

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  47 in total

1.  High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.

Authors:  Preethi Samuel; Quaisar Ali; Rifat Sabuhi; Yonnie Wu; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-16

Review 2.  Proximal tubular function and salt sensitivity.

Authors:  Michel Burnier; Murielle Bochud; Marc Maillard
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 3.  Pathogenesis of essential hypertension: historical paradigms and modern insights.

Authors:  Richard J Johnson; Dan I Feig; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Bernardo Rodriguez-Iturbe
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

4.  Blood pressure follows the kidney: Perinatal influences on hereditary hypertension.

Authors:  Maarten P Koeners; Branko Braam; Jaap A Joles
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

Review 5.  MicroRNA: a new frontier in kidney and blood pressure research.

Authors:  Mingyu Liang; Yong Liu; Domagoj Mladinov; Allen W Cowley; Hariprasad Trivedi; Yi Fang; Xialian Xu; Xiaoqiang Ding; Zhongmin Tian
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-01

6.  Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study.

Authors:  Arrigo Francesco Giuseppe Cicero; Giovambattista Desideri; Giulia Grossi; Riccardo Urso; Martina Rosticci; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2014-07-02       Impact factor: 3.397

Review 7.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

Review 8.  Genetics of salt-sensitive hypertension.

Authors:  Hironobu Sanada; John E Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

9.  Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.

Authors:  Miguel L Graciano; Akira Nishiyama; Keith Jackson; Dale M Seth; Rudy M Ortiz; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-07

10.  Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.

Authors:  Niwanthi W Rajapakse; Carmen De Miguel; Satarupa Das; David L Mattson
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.